Inpharmus is a pharmaceutical company that specialises in enabling access to innovative treatments for 350 million people living in major emerging markets

Inpharmus is dedicated to advancing innovation across carefully targeted therapeutic areas, leveraging its expertise to develop and distribute treatments to improve patient outcomes.